Fatal invasive pulmonary aspergillosis in non-immunocompromised host: A case report

被引:2
作者
Ao, Wanping [1 ]
Huang, Ping [1 ]
Wang, Jinjing [2 ]
Fu, Xiaoyun [1 ]
Fu, Bao [1 ]
机构
[1] Zunyi Med Univ, Dept Crit Care Med, Affiliated Hosp, Zunyi City 563000, Peoples R China
[2] Zunyi Med Univ, Dept Pathol, Affiliated Hosp, Zunyi City, Peoples R China
关键词
combination therapy; invasive pulmonary aspergillosis; non-immunocompromised host; voriconazole; B LIPID COMPLEX; AMPHOTERICIN-B; EFFICACY; VORICONAZOLE; GUIDELINES; MANAGEMENT; DIAGNOSIS; SAFETY;
D O I
10.1097/MD.0000000000035702
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale:Invasive pulmonary aspergillosis (IPA) is an uncommon but life-threatening disease. The disease often occurs in immunocompromised patients or critically ill patients. Here, we reported that IPA occurred in a non-immunocompromised host.Patient concerns:A 45-year-old man was admitted to the hospital for 1 week due to fever and cough. He was engaged in waste recycling and lived in a dark and humid environment for a long time.Diagnosis:Invasive pulmonary aspergillosis.Interventions:Next generation sequencing and pathological examination of alveolar lavage fluid indicated aspergillus infection. He received voriconazole infusion after admission. After 5 weeks of antifungal treatment, his condition improved significantly and discharged.Outcome:One week after discharge, his condition deteriorated again and returned to the hospital. Unfortunately, he died.Lesson:The immunocompetent adults can develop invasive pulmonary aspergillosis if they are exposed to high-risk environments. IPA in non-immunocompromised host should arouse the vigilance of clinicians.
引用
收藏
页数:3
相关论文
共 19 条
[1]   Echinocandins for the Treatment of Invasive Aspergillosis: from Laboratory to Bedside [J].
Aruanno, Marion ;
Glampedakis, Emmanouil ;
Lamoth, Frederic .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)
[2]   The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies [J].
Bergeron, Anne ;
Porcher, Raphael ;
Sulahian, Annie ;
de Bazelaire, Cedric ;
Chagnon, Karine ;
Raffoux, Emmanuel ;
Vekhoff, Anne ;
Cornet, Muriel ;
Isnard, Francoise ;
Brethon, Benoit ;
Lacroix, Claire ;
Poirot, Jean Louis ;
Bouges, Claire ;
Derouin, Francis ;
Tazi, Abdellatif ;
Ribaud, Patricia .
BLOOD, 2012, 119 (08) :1831-1837
[3]   Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients [J].
Chandrasekar, PH ;
Ito, JI .
CLINICAL INFECTIOUS DISEASES, 2005, 40 :S392-S400
[4]   Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis [J].
Denning, DW ;
Ribaud, P ;
Milpied, N ;
Caillot, D ;
Herbrecht, R ;
Thiel, E ;
Haas, A ;
Ruhnke, M ;
Lode, H .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (05) :563-571
[5]  
Dominelli GS, 2013, J BRONCHOL INTERN PU, V20, P326, DOI 10.1097/LBR.0000000000000002
[6]   Spectrum of pulmonary aspergillosis:: Histologic, clinical, and radiologic findings [J].
Franquet, T ;
Müller, NL ;
Giménez, A ;
Guembe, P ;
de la Torre, J ;
Bagué, S .
RADIOGRAPHICS, 2001, 21 (04) :825-837
[7]   Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign [J].
Greene, Reginald E. ;
Schlamm, Haran T. ;
Oestmann, Joerg -W. ;
Stark, Paul ;
Durand, Christine ;
Lortholary, Olivier ;
Wingard, John R. ;
Herbrecht, Raoul ;
Ribaud, Patricia ;
Patterson, Thomas F. ;
Troke, Peter F. ;
Denning, David W. ;
Bennett, John E. ;
de Pauw, Ben E. ;
Rubin, Robert H. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (03) :373-379
[8]   Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients [J].
Herbrecht, R ;
Auvrignon, A ;
Andrès, E ;
Guillemain, R ;
Suc, A ;
Eyer, D ;
Pailler, C ;
Letscher-Bru, V ;
Leverger, G ;
Schaison, G .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (02) :77-82
[9]   Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis [J].
Herbrecht, R ;
Denning, DW ;
Patterson, TF ;
Bennett, JE ;
Greene, RE ;
Oestmann, JW ;
Kern, WV ;
Marr, KA ;
Ribaud, P ;
Lortholary, O ;
Sylvester, R ;
Rubin, RH ;
Wingard, JR ;
Stark, P ;
Durand, C ;
Caillot, D ;
Thiel, E ;
Chandrasekar, PH ;
Hodges, MR ;
Schlamm, HT ;
Troke, PF ;
de Pauw, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (06) :408-415
[10]   Tracheobronchial Manifestations of Aspergillus Infections [J].
Krenke, Rafal ;
Grabczak, Elzbieta M. .
THESCIENTIFICWORLDJOURNAL, 2011, 11 :2310-2329